---
aliases:
  - BI
---
#actor #pharma #germany #private

Boehringer Ingelheim -- privately held German pharmaceutical company. Partner with [[Zealand Pharma]] on survodutide (dual GLP-1/glucagon agonist) for obesity and MASH.

## Quick stats

| Metric | Value |
|--------|-------|
| HQ | Ingelheim, Germany |
| Ownership | Private (Boehringer/von Baumbach family) |
| Revenue | ~$28B (2024) |
| Focus | Cardiometabolic, respiratory, oncology |

## Related

- [[Zealand Pharma]] -- survodutide partner
- [[GLP-1 receptor agonists]] -- survodutide pipeline
- [[Biopharma]] -- sector

*Stub -- expand when relevant*
